Benefits of yoga therapy for heart problem patients.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Heart failure (NYHA I & II)
- Registration Number
- CTRI/2012/06/002734
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 96
Inclusion Criteria
Patients with systolic and / or diastolic heart failure
New York Heart Association (NYHA) class I & II
EjectionFraction: 30-50%
Able to walk without assistance
On stable medical therapy for heart failure.
Exclusion Criteria
Valvular heart disease
Pregnant or breast-feeding
Currently addicted to alcohol or drugs.
Patients having COPD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Cardiac function assessed by Echocardiography. <br/ ><br>2. Functional capacity assessed by 6 min walk test. <br/ ><br>3.Oxidative stress: Total antioxidant status, Plasma MDA. <br/ ><br>4.Biomarkers: <br/ ><br> Neurohormones â?? N terminal pro BNP. <br/ ><br>Inflammation â?? hs CRP,TNFα <br/ ><br> Oxidative stress marker â?? Plasma MDA, Uric acid <br/ ><br>Hormonal and other markers of cachexia â?? Cholesterol <br/ ><br> Comorbidities â?? Hb%, Creatinine <br/ ><br>Timepoint: 0 days, After 12 weeks of Yoga Therapy
- Secondary Outcome Measures
Name Time Method Cardiac autonomic function assessed by short term Heart Rate Variability. <br/ ><br>QoL, Depression, Dyspnoea grading. <br/ ><br>Timepoint: 0 days, after 12 weeks of Yoga Therapy